Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Xeris Biopharma Holdings (XERS) Shares Issued (2021 - 2025)

Historic Shares Issued for Xeris Biopharma Holdings (XERS) over the last 5 years, with Q3 2025 value amounting to $5.2 million.

  • Xeris Biopharma Holdings' Shares Issued changed N/A to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 152366.2%. This contributed to the annual value of $1.2 million for FY2024, which is 12659.38% up from last year.
  • Per Xeris Biopharma Holdings' latest filing, its Shares Issued stood at $5.2 million for Q3 2025.
  • Xeris Biopharma Holdings' 5-year Shares Issued high stood at $30.0 million for Q1 2022, and its period low was $251000.0 during Q2 2024.
  • Over the past 5 years, Xeris Biopharma Holdings' median Shares Issued value was $972000.0 (recorded in 2025), while the average stood at $7.8 million.
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 5428.05% in 2024, then soared by 95904.14% in 2025.
  • Quarter analysis of 5 years shows Xeris Biopharma Holdings' Shares Issued stood at $27.0 million in 2021, then increased by 11.11% to $30.0 million in 2022, then tumbled by 98.17% to $549000.0 in 2023, then dropped by 2.73% to $534000.0 in 2024, then soared by 866.48% to $5.2 million in 2025.
  • Its Shares Issued was $5.2 million in Q3 2025, compared to $972000.0 in Q2 2025 and $4.9 million in Q1 2025.